Depressive State and Paresthesia Dramatically Improved by Intravenous MgSO4 in Gitelman's Syndrome

Mayumi Enya, Yoshinori Kanoh, Tomoatsu Mune, Masayoshi Ishizawa, Hiroshi Sarui, Mayumi Yamamoto, Noriyuki Takeda, Keigo Yasuda, Minoru Yasujima, Shoji Tsutaya,

Internal Medicine · 2004 · 18 citations · 17 references

DOIFull text

Open access

Concepts

Abstract

A 69-year-old woman was referred to our department for evaluation of hypokalemia, which had been treated by oral potassium for more than ten years. She complained of headache, knee joint pain, sleeplessness and paresthesia in extremities and, most prominently, depression. Laboratory data suggested Gitelman's syndrome, which is caused by mutations in the gene encoding the thiazide-sensitive Na-Cl cotransporter. Direct sequencing of the gene in this patient revealed homozygous mutation R964Q in exon 25. Intravenous supplement of MgSO4 dramatically improved both the depression and the paresthesia, suggesting that hypomagnesemia played a role in the clinical manifestations.

References

17